Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Research & Development of $39.02 million for Q2 2026, down 18.7% from $47.96 million a year earlier but up 1.7% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Amneal Pharmaceuticals was $175.57 million, down 13.7% year-over-year; for FY2025, it came in at $186.18 million, down 2.4% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
- In prior years, Amneal Pharmaceuticals' Research & Development was $190.71 million in FY2024 (+16.3%), $163.95 million in FY2023 (-16.2%), $195.69 million in FY2022 (-3.1%) and $201.85 million in FY2021 (+12.2%).
- Quarterly Research & Development has run from a low of $34.82 million in Q4 2025 to a high of $63.35 million in Q3 2025 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last three quarters, with growth averaging 5.7% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 47.7%; the weakest was Q4 2025, with a decline of 35.8%.
- According to Business Quant data, Research & Development for the three prior quarters was $38.38 million (Q1 2026), $34.82 million (Q4 2025) and $63.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Amneal Pharmaceuticals | 6.55 Bn | 5.82 Bn | 334.51 Mn | 39.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.02 Mn |
| Mar 31, 2026 | 38.38 Mn |
| Dec 31, 2025 | 34.82 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Jun 30, 2025 | 47.96 Mn |
| Mar 31, 2025 | 40.04 Mn |
| Dec 31, 2024 | 54.27 Mn |
| Sep 30, 2024 | 61.10 Mn |
| Jun 30, 2024 | 36.05 Mn |
| Mar 31, 2024 | 39.30 Mn |
| Dec 31, 2023 | 46.09 Mn |
| Sep 30, 2023 | 41.38 Mn |
| Jun 30, 2023 | 37.80 Mn |
| Mar 31, 2023 | 38.69 Mn |
| Dec 31, 2022 | 41.91 Mn |
| Sep 30, 2022 | 50.24 Mn |
| Jun 30, 2022 | 50.75 Mn |
| Mar 31, 2022 | 52.80 Mn |
| Dec 31, 2021 | 51.87 Mn |
| Sep 30, 2021 | 48.93 Mn |
API Access
Amneal Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();